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ABSTRACT 
We report the case of a 50-year old male patient presenting with a combination of 
chondrocalcinosis and osteoporosis related to a renal tubular disorder. Laboratory studies 
revealed hypokalemia, hypomagnesemia, hypocalcemia with renal wastage and metabolic 
alkalosis, compatible with a renal tubular transport disorder with similarities to Bartter’s and 
Gitelman’s syndrome. Calcifications of the menisci and cartilage on X-rays of knee joints 
suggested chondrocalcinosis, which has been associated with Gitelman’s syndrome. 
Radiologically suspected osteopenia was confirmed by a bone density scan that revealed 
osteoporosis of the vertebral column. An association of osteoporosis with hypercalciuria, 
which commonly occurs in Bartter’s syndrome patients, has been reported. Upon treatment of 
the renal tubular disorder with spironolactone and a thiazide diuretic in combination with 
calcium and magnesium supplementation, the electrolyte abnormalities resolved and 
arthralgias disappeared. Our case demonstrates a renal tubular dysfunction with features of 
both Bartter’s and Gitelman’s syndrome along with concurrent chondrocalcinosis and 
osteoporosis. Furthermore, the occurrence of osteoporosis in this relatively young patient, in 
the absence of other risk factors, demonstrates that renal tubular disorders should be suspected 
in presenile osteoporosis. Vice versa, since osteoporosis usually is asymptomatic before 
fracturing, patients with renal tubular disorders should be examined for osteoporosis. 
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CASE REPORT 
 
The male patient first presented at the age of 
49, with arthralgias of hands, feet and 
shoulders, early morning stiffness and leg 
cramps. Weakness in the right hand was 
attributed to a carpal tunnel syndrome. The 
patient had a daily intake of two glasses of 
wine, no history of vomiting, and he was 
taking no medications with the exception of 
diclofenac in a dose of 100 mg/d. At the age 
of twenty he suffered a traumatic fracture of  
 
his left hip, which was treated with a total 
endoprosthesis. 
 
Physical examination revealed the patient to 
be afebrile with a blood pressure of 130/90 
mmHg and a heart rate of 87/min. He was 
overweight with a body mass index of 32. No 
synovialitis was detectable on physical 
examination. Gaenslen’s sign was positive on 
the left foot. Physical examination of heart, 
lungs, and abdomen was normal. 
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Neurological examination displayed 
muscular weakness in the right hand but no 
sensory deficit. 
 
Blood tests revealed hypokalemia, 
hypomagnesemia, hypocalcemia, while 
serum levels of sodium and phosphate were 
normal. Urinary potassium, magnesium and 
calcium were high in face of their low serum 
concentrations (summarised in Table 1), 
consistent with renal wasting. Blood gas 
analysis revealed metabolic alkalosis. A 
complete blood count and coagulation tests 
showed no abnormalities. Values for serum 
protein concentration, liver enzymes, alkaline 
phosphatase, and for 1,25 (OH)2 vitamin D 
were normal, while intact parathyroid 
hormone (PTH) was elevated. Plasma 
aldosterone levels and urine aldosterone-18-
glucuronide metabolites were increased. Both 
serum creatinine and creatinine clearance 
were normal, indicating normal glomerular 
filtration. Slightly elevated titers of 
antinuclear antibodies (ANA) were found, 
while titers of extractable nuclear antibodies, 
anti-neutrophilic cytoplasmic antibodies, and 
rheumatoid factor were negative. Serum 
levels of telopeptides (ICTP) were increased, 
whereas osteocalcin was normal. Finally, the 
ratio of urinary deoxypyridinoline to 
creatinine was increased, indicating bone 
resorption. 
 
Radiographic analysis showed articular and 
periarticular calcifications in the shoulders, 
knees, and feet consistent with 
chondrocalcinosis (Fig. 1). Moreover, 
osteopenia was demonstrated in the lumbar 
spine without signs of fractures. Bone density 
scan revealed osteopenia with a T-score 
value of –2.0 in the Ward’s triangle of the 
femur and osteoporosis with a value of –2.7 
in the lumbar spine. 
 
 
Figure 1. Radiography of the knee shows calcification of the menisci (arrows). 
 
Taken together the electrolyte abnormalities 
suggested a renal tubular disorder. The 
arthralgias were interpreted in the context of 
calcium pyrophosphate crystal deposition. 
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Symptomatic treatment was begun with a 
non-steroidal anti-inflammatory drug 
(NSAID). The renal tubular disorder was 
treated with spironolactone in combination 
with a thiazide diuretic and supplementation 
of calcium and magnesium. Within several 
weeks the serum electrolytes returned to 
almost normal values (Table 1) and 
arthralgias and morning stiffness subsided. 
 
Table 1. Composition of important laboratory findings. 1st values were obtained at 
admission, 2nd values 4 weeks after beginning of the treatment. 
 
Marker 1st value  2nd value Reference values 
Arterial Blood Gas 
Analysis 
   
 pH (37°C) 7.499 7.438 7.36-7.44 
 pCO2 (37°C) 4.9 kPa 5.23 kPA 4.6-6.0 kPa 
 pO2 (37°C) 16.59 kPa  12-13.3 kPa 
 HCO-3 28.4 mmol/l 25.9 mmol/l 22-26 mmol/l 
 BE (+)5.4 mmol/l  (-)2.0-(+)2.0 mmol/l 
Serum    
 Potassium 2.8 mmol/l 3.4 mmol/l 3.5-4.5 mmol/l 
 Calcium (total) 2.06 mmol/l 2.3 mmol/l 2.1-2.6 mmol/l 
 Magnesium 0.37 mmol/l 0.42 mmol/l 0.65-1.00 mmol/l 
 Phosphate 0.86 mmol/l  0.6-1.3 mmol/l 
 Albumin 39.0 g/l 44.0 g/l 40-50 g/l 
 Creatinine 95 µmol/l 104 µmol/l 70-105 µmol/l 
 Alkaline 
 Phosphatase 
69 U/l  30-115 U/l 
 Trijodthyronine 4.9 pmol/l  2.8-7.1 pmol/l 
 Testosterone 15.5 nmol/l  8.2-35 nmol/l 
 Aldosterone 514 pmol/l  55-330 pmol/l 
 Parathyroid hormone 77.0 ng/l  12-72 ng/l 
 25-Hydroxy-Vit D 26.8 µg/l  10-42 µg/l 
Telopeptide (ICTP) 5.9 µg/l  1.8-5.0 µg/l 
 Osteocalcin 4.19 µg/l  3.4-11.7 µg/l 
Urine chemistry    
 Potassium 55.6 mmol 87.8 mmol 35-90 mmol 
 Magnesium 6.06 mmol  3.0-5.0 mmol 
 Phosphate 18.88 mmol 24.55 mmol 12.9-42.0 mmol 
 Calcium 3.04 mmol 2.22 mmol < 7.5 mmol 
 Aldosterone-
Glucuronide 
42 nmol/24h  6-36 nmol/24h 
 Ratio 
deoxypyridinoline 
/Creatinine 
5.5 nmol/mmol  2.5-5.0 nmol/mmol 
 
 
DISCUSSION 
 
The described patient presents with an 
unusual combination of chondrocalcinosis 
and osteoporosis related to a renal tubular 
disorder, displaying features of both Bartter’s 
and Gitelman’s syndrome, as underlying 
disease. Bartter’s syndrome is caused by 
impaired tubular reabsorption of sodium by 
the Na/K/2Cl cotransporter in the thick 
ascending limb of Henle. This results in 
increased distal delivery of sodium to the 
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collecting duct, favouring enhanced proton 
secretion, inducing metabolic alkalosis. In 
comparison, the molecular defect in 
Gitelman’s syndrome is in the Na/Cl 
cotransporter residing in the distal tubule. 
Whereas in patients with Gitelman’s 
syndrome hypocalciuria and 
hypermagnesiuria with hypomagnesemia is 
common, patients with Bartter’s syndrome 
characteristically show hypercalciuria and 
usually normal serum magnesium (Gitelman 
et al., 1966; Kurtz, 1998), however, 
hypomagnesemia in patients with Bartter’s 
disease has been previously reported 
(Bettinelli et al., 1992). Whereas in our 
patient the hypermagnesiuria and also the 
reported muscle cramps suggested 
Gitelman’s syndrome, hypocalcemia and 
hypercalciuria rather indicated Bartter’s 
disease. In conclusion, the exact molecular 
nature of the renal tubular transport defect in 
our patient remains elusive. However, the 
clinical findings suggest a link between the 
renal electrolyte disorder and the 
pathological skeletal findings. An association 
of hypomagnesemia with chondrocalcinosis 
has been suggested by several studies and 
case reports (Jones et al., 1992; Salvarani et 
al., 1989; Smilde et al., 1994). There has 
been some controversy over the association 
of Bartter’s syndrome and chondrocalcinosis. 
Evidence has been presented indicating that 
previous reports of cases of Bartter’s 
syndrome associated with chondrocalcinosis 
may actually rather be diagnosed as 
Gitelman’s syndrome (Punzi et al., 1998). 
 
Interestingly, bone densitometry in our 
patient revealed osteoporosis of the lumbar 
spine. Additionally, serum carboxy-terminal 
telopeptide of type I collagen (ICTP) and 
urine deoxypyridinoline were elevated, 
indicating bone resorption (Kushida et al., 
1995; Seibel et al., 1993). Osteoporosis 
commonly progresses silently for long time 
periods until fractures occur, along with pain 
being frequently the only symptom of this 
disease. Conditions known to cause 
osteoporosis are of genetic, functional, 
environmental or endocrine origin 
(Sambrook et al., 1998). In our patient, 
genetic and functional disorders could be 
excluded on clinical grounds, and 
hyperthyroidism and hypogonadism by 
normal findings of the respective hormones. 
The patient history and biochemical markers 
did not reveal evidence of alcohol abuse, an 
important risk factor for osteoporosis. There 
were slightly increased levels for intact PTH, 
probably secondary to hypocalcaemia; 
however, levels of serum phosphate and 
alkaline phosphatase were normal. 
Hypercalciuria, as found in Bartter’s 
syndrome, has been associated with 
osteoporosis (Laroche et al. 1994; Perry et 
al., 1982). Laroche et al. (1994) found 
hypercalciuria due to renal tubular disorders 
in a significant proportion of osteoporotic 
men. These tubular disorders were frequent 
among younger osteoporotic patients with a 
mean age of 45 +/- 8 years, warranting 
assessment of renal tubular function in these 
patients. On the other hand, because of the 
silent progression of osteoporosis for decades 
before the presentation of clinical features, 
individuals with hypocalcaemic renal tubular 
disorder should be screened by bone 
densitometry. 
 
In summary, we reported on a patient with 
osteoporosis and chondrocalcinosis suffering 
from renal tubular dysfunction sharing 
clinical similarities with Bartter’s and 
Gitelman’s syndrome. Both osteoporosis, 
associated with hypercalciuria as occurring in 
Bartter’s syndrome, and chondrocalcinosis, 
associated with Gitelman’s syndrome, can be 
accounted for by the complex electrolyte 
changes due to the tubular disorder. Such 
association is supported by the rapid 
normalization of the electrolyte disturbances 
upon treatment with spironolactone and 
thiazide in combination with calcium and 
magnesium supplementation, accompanied 
by the disappearance of clinical symptoms. 
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